Cargos activos de Rebecca Cohen
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| IKENA ONCOLOGY, INC. | Contacto de Relaciones con Inversores | - | - |
Historial de carrera de Rebecca Cohen
Antiguos cargos conocidos de Rebecca Cohen.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Contacto de Relaciones con Inversores | 01/01/2017 | 01/07/2018 |
| Public Communications Contact | 01/01/2017 | 01/07/2018 | |
| EPIZYME, INC. | Public Communications Contact | - | 01/05/2016 |
Estadísticas
Internacional
| Estados Unidos | 4 |
Operativa
| Public Communications Contact | 2 |
| Investor Relations Contact | 2 |
Sectorial
| Health Technology | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Health Technology |
| IKENA ONCOLOGY, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Rebecca Cohen
- Experiencia